Recent Updates
Recently added Catalysts
HSIC Positive Sentiment

Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET

Tuesday, July 21, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Henry Schein, Inc. will announce its second quarter 2026 financial results on August 4, 2026, prior to market opening. The company will host a live webcast of its earnings conference call at 8:00 a.m. ET, featuring CEO Fred Lowery among the speakers. This event emphasizes the company's commitment to transparency with investors.
Price reaction · baseline $86.2 (2026-07-20 close) · hit pre-market · clean, no other HSIC news in the window
day 0 close
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Henry Schein is releasing its financial results, indicating transparency.
  • The webcast allows stakeholders to engage directly with company leadership.
  • Scheduled timing aligns with market opening, enhancing accessibility.

Full Press Release Details

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer and

Frequently Asked Questions

When will Henry Schein release its Q2 2026 results?

Henry Schein will release its Q2 2026 financial results on August 4, 2026.

What time is the Q2 2026 earnings call?

The earnings call will begin at 8:00 a.m. Eastern time on August 4, 2026.

Who will speak on the earnings call?

CEO Fred Lowery will be among the speakers during the earnings call.

How can I access the earnings call?

The earnings call will be available via a live webcast on the same day.

ShareAdd on Google
Tags: HSIC Henry Schein earnings call financial results webcast
Last updated: Jul 21, 2026

Biotech snapshot

Cash runway
$157M liquidity · $0M/mo burn
Low dilution risk